Suchergebnisse - "Personeni, Nicola"

PubPharm (8)

1

Role of liver biopsy in hepatocellular carcinoma

enthalten in: World journal of gastroenterology | 2019

von Di Tommaso, L. | Spadaccini, M. | Donadon, M. | +4

2

Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy : heterogeneity-related issues and prognostic implications

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2017

von Personeni, N. | Baretti, M. | Bozzarelli, S. | +9

3

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

enthalten in: Oncotarget | 2016

von Rimassa, L. | Abbadessa, G. | Personeni, N. | +17

4

KRAS mutation in lung metastases from colorectal cancer : prognostic implications

enthalten in: Cancer medicine | 2016

von Ghidini, M. | Personeni, N. | Bozzarelli, S. | +12

5

Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma

enthalten in: Journal of cancer research and clinical oncology | 2013

von Personeni, N. | Rimassa, L. | Pressiani, T. | +9

6

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma

enthalten in: Journal of hepatology | 2012

von Personeni, N. | Bozzarelli, S. | Pressiani, T. | +7

7

Standardisation of EGFR FISH in colorectal cancer : results of an international interlaboratory reproducibility ring study

enthalten in: Journal of clinical pathology | 2012

von Sartore-Bianchi, A. | Fieuws, S. | Veronese, S. | +13

ErratumIn: J Clin Pathol. 2012 Jul;65(7):674

8

Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer : the role of anthracycline dose intensity

enthalten in: American journal of clinical oncology | 2006

von Bozzetti, C. | Musolino, A. | Camisa, R. | +10

1
[1]